Form 4: Cigna Chief Accounting Officer Executes Stock Option
Statement of Changes in Beneficial Ownership
Cigna Group Chief Accounting Officer Jamie G. Kates exercised 899 stock options and subsequently sold the shares.
Summary
- Jamie G. Kates, Chief Accounting Officer of The Cigna Group, exercised 899 employee stock options at a strike price of $152.8947 on June 12, 2026.
- Following the exercise, the reporting person sold all 899 shares at an average price of $298.612 per share.
- The transaction resulted in a net reduction of derivative holdings to zero for this specific grant, while the reporting person retains 2,368 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine exercise of vested compensation rather than a strategic move or a signal of insider sentiment.
Positives
- The transaction reflects the exercise of long-term incentive compensation granted in 2018, indicating the executive's participation in the company's equity-based compensation program.
Negatives
- The immediate sale of the acquired shares suggests a liquidity event rather than an increase in long-term equity stake by the executive.
Risks
- None identified; this is a routine disclosure of executive compensation activity.
Future Outlook
No forward-looking guidance or strategic outlook provided in this filing.
Industry Context
StockSavvy.ai notes that routine Form 4 filings regarding option exercises by C-suite executives are standard corporate governance disclosures and generally do not signal shifts in company strategy or fundamental health.
Comparison to Industry Standards
- The transaction aligns with standard executive compensation practices observed at large-cap healthcare firms like UnitedHealth Group and CVS Health, where executives periodically exercise vested options as part of their personal financial planning.
Stakeholder Impact
- Minimal impact on shareholders as the transaction size is relatively small and represents standard executive compensation activity.
Next Steps
- None mentioned.
Key Dates
| Date | Description |
|---|---|
| 02/28/2018 | Original grant date of the employee stock options. |
| 02/28/2019 | Initial vesting date of the stock options. |
| 06/12/2026 | Date of the option exercise and subsequent share sale. |
| 06/16/2026 | Date of filing with the SEC. |
Keywords
Cigna, CI, Form 4, Insider Trading, Executive Compensation, Stock Options
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.